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Abstract 
Purpose:  Wolfram syndrome is characterized by early onset diabetes mellitus, diabetes 
insipidus, deafness and optic atrophy, but retinal degeneration has not been described as a major 
component of the phenotype. We present two cases with Wolfram syndrome and evidence of 
retinal degeneration. 
 
Materials and Methods:  Observational case series. Patients underwent complete ocular 
examinations as well as retinal imaging and electroretinography. 
 
Results:  Both patients had electroretinographic evidence of retinal dysfunction/degeneration in 
addition to optic atrophy with an otherwise normal-appearing retina. 
 
Conclusions:  Some patients with Wolfram syndrome have a mild retinal degeneration that may 
be a manifestation of the neuronal involvement that is present in this condition.   
 
Keywords:  Wolfram syndrome, optic atrophy, retinal degeneration, electroretinography, 
diabetes mellitus, diabetes insipidus 
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Introduction 
Wolfram syndrome is a rare autosomal recessive disorder characterized by diabetes insipidus, 
sensorineural hearing loss, and neurodegenerative features such as cerebellar ataxia and brainstem 
atrophy 1–5. However, only 75% of patients with Wolfram show the full clinical phenotype1–5. The main 
diagnostic criterion is the combination of optic atrophy and the onset of diabetes mellitus before the 
age of 16 years1,6. In a natural progression study of this disease, the authors argue that the positive 
diagnostic predictive value of the combination of bilateral optic atrophy and diabetes is 83%6. 
The syndrome has been linked to mutations in the Wolfram syndrome gene (WFS1), which 
encodes an endoplasmic reticulum membrane protein, Wolframin7. Greater than 90% of patients 
with Wolfram syndrome have mutations in WFS18.  We present two patients with Wolfram 
syndrome with mutations in WFS1 who demonstrate evidence of retinal 
degeneration/dysfunction, in addition to optic atrophy, diabetes mellitus, and diabetes insipidus. 
 
Materials and methods 
Observational case series of two patients identified upon chart review of all cases of 
Wolfram syndrome examined between 2000 and 2017 with positive genetic testing and abnormal 
electroretinographic findings. During the study period, we observed 7 cases of Wolfram 
syndrome. Among these, we have included the patients with positive genetic testing and 
abnormal electroretinographic findings. We have performed ERG on another 9 year-old boy, and 
found it to be normal. No ERG was performed in the other 4 patients.  The study was approved 
by the Cleveland Clinic IRB and patients consented to participate. A comprehensive ophthalmic 
examination was performed including best-corrected visual acuity, cycloplegic refraction, ocular 
motility, stereopsis, color vision testing using Ishihara plates (38 Plates Ishihara Booklet Edition 2017, 
Kanehara Trading In., Tokyo, Japan), direct and consensual pupillary light reflexes, slit-lamp 
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biomicroscopy, fundus examination, Goldmann visual field testing, optical coherence tomography (OCT) 
of the optic nerves and retina (Cirrus HD-OCT Version 8.0 software,, Carl Zeiss Meditec, Jena, Germany), 
electroretinography (ERG) (LKC Technologies, Gaithersburg, MD) and molecular genetic testing (CLIA 
certified laboratory). 
 
Results 
 
Case One:   
A 22 year-old woman was examined before beginning a laboratory technician job that 
required good color discrimination.  She had been diagnosed with type I diabetes at the age of 7, 
and had subsequently also developed an overactive bladder, as consequence of bladder neuropathy, 
treated with solifenacin. Best corrected visual acuity was 20/25 in the right eye and 20/40 in the left 
eye. Her refraction was +1.00 x 20 in OD and +0.50 +1.00 x 140 in OS. She could identify only the test 
plate in OD and only 8/11 in OS.  There was no afferent pupillary defect in either eye.  The 
anterior segment of both eyes was normal. There was mild disc pallor in both eyes, but the 
fundus appeared otherwise normal, except for a low grade of vessels’ narrowing (Figure 1). An MRI 
of the brain and the orbits with contrast had been obtained and was normal.  Light-adapted 0 ERG 
and light-adapted 30 Hz Flicker were reduced in amplitude. The dark-adapted 24 ERG and dark-
adapted 0 ERG were also decreased in amplitude (Figure 2). Goldmann visual fields 
demonstrated marked bilateral circumferential constriction. The Macula OCT looks normal and 
the Optic Nerve OCT shows diffuse Nerve Fiber Layer loss in both eyes. Genetic testing was 
obtained for autosomal dominant optic atrophy, and Wolfram syndrome, although the suspicion 
for the latter was high in the setting of diabetes mellitus and diabetes insipidus.  Two mutations 
in WFS1 were identified. One was a known pathogenic mutation, c.2648_2651delTCTT; p. 
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F883fs*, and the second, a novel likely pathogenic mutation, c.757 A>T; p.K253X, that 
produces a truncated protein at amino acid 253. 
 
Case Two: 
 A 26 year-old man was referred in with a known diagnosis of Wolfram syndrome.  He 
carried known pathogenic homozygous mutations in exon 8 of the WFS1 gene, 
c.1441_1447dupCTGA; p.Val483Ala. The parents were first cousins.  The patient had presented 
to an ophthalmologist with decreased vision after head trauma at age 6 and the vision loss was 
attributed to the injury. One year after vision decreased further and the patient developed 
diabetes mellitus and diabetes insipidus. Best corrected visual acuity was 20/160 in the right eye 
and 20/320 in the left eye and has remained stable.  The patient had moderately high myopia:  
OD -8.25 +4.25 x 95, OS -9.25 +5.75 x 85.  Anterior segment exam was unremarkable initially, 
but he gradually developed mild cataracts. Similar to case 1, ophthalmoscopy was notable only 
for marked disc pallor, without fundus abnormalities (Figure 3). The ERG demonstrated 
significantly attenuated cone responses with absence of b-wave on light-adapted 0 ERG. Rod 
responses were also markedly decreased in amplitude on dark-adapted -24 ERG and dark-
adapted 0 ERG (Figure 2). Goldmann visual fields demonstrated marked bilateral circumferential 
constriction. 
 
Discussion 
 
Wolfram syndrome is a complex autosomal recessive disorder in which patients present 
with optic atrophy in the setting of non-autoimmune juvenile diabetes, and progress to develop 
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deafness, renal failure and neurologic dysfunction1,6.  A large proportion of patients suffer from 
psychiatric and neurologic problems, and in most patients death occurs early, often because of 
respiratory failure secondary to brain atrophy8.  It is for all these reasons as well as for genetic 
counseling that early diagnosis is critical. Our goal is to broaden the understanding of the clinical 
spectrum of this condition and include retinal degeneration to the list of ophthalmic findings.  
There have been a few reported cases with abnormal ERGs, but this has not been well 
explained1.   
Gunn et al described four patients in 1976 with juvenile diabetes mellitus, optic atrophy, 
sensorineural hearing loss, and diabetes insipidus, and one of these patients demonstrated 
granular changes in the macula with a normal ERG, while the rest had normal fundi with ERG 
abnormalities9. Of these three patients, the first was a 17 year-old girl with elevated ERG 
threshold and diminished amplitude in dark-adapted ERG, a normal cone response, diminished 
dark-adapted oscillatory potential and abnormal dark adaptation; the second was also a 17 year-
old girl with an elevated ERG threshold and diminished amplitudes of dark- and light-adapted 
responses, diminished dark-adapted oscillatory potential and abnormal dark adaptation; the third 
patient was a 17 year-old boy with elevated threshold and reduced cone response amplitudes9. 
Rose et al published a series of seven patients in 1966 with juvenile diabetes and optic atrophy, 
of whom two demonstrated fine granular changes to the retina. Electroretinography was normal 
in one patient, and abnormal in the second10.  Of note, in this series, the diagnosis was unclear, as 
patients had findings compatible with Friedreich ataxia as well as Refsum disease10. In 1972 
Niemeyer and Marquardt described two siblings with retinal function alteration11. They found a 
relative sparing in external retinal layers since the ERG was only slightly reduced, with a 
detectable defect in the cone than in the rod system, and elevated cone and rod thresholds on 
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dark adaptation testing11. In 2005, Dedes et al. specifically noted that a patient with Wolfram 
syndrome had a normal ERG, “excluding tapetoretinal degeneration” as part of the differential 
diagnosis5. In a large series published by Cremers and Wijdeveld et al, 88 cases of Wolfram 
syndrome were reviewed in the context of 3 newly diagnosed patients1.  Electroretinography was 
performed in two of the new patients and it was described as normal in both.1 Of the 88 case 
reports they reviewed, only 19 underwent ERG testing, the large majority of which were 
normal1.  Pigmentary changes of the retina was present in 9% of the patients, but no correlation 
was made between ERG and fundus findings1.  Barrett and Bundey analyzed 45 cases and found 
that none had pigmentary retinal changes12.  However 6 of their patients underwent ERG testing 
of which 50% were normal, and the other 50% revealed a reduction in amplitude without a 
significant change in latency12.  In a small series published from the Middle East, Al-Till et al. 
discussed 15 patients with Wolfram syndrome in 4 families2. Nine of 30 eyes had retinal 
pigmentary changes. A normal fovea and fluorescein angiogram were documented in all patients 
but ERGs were not performed2.  Mtanda et al. reiterated that in the first description of 11 patients 
with Wolfram syndrome in 1986, one had pigmentary retinal degeneration, the vast majority had 
some degree of cataract, and all had normal ERG and EOG4. Authors described a diminution of 
the dark adaptation curve characterized by a reduction in of both cone and rod adaptation4. In 
2012 a report on the clinical and electrophysiological findings of 5 members of a family with 
WFS1 mutations showed variable degrees of changes in pattern-reversal visual evoked potentials 
of all patients, while dark- and light- adapted responses were of normal morphology and 
amplitudes on flash electroretinography13. No evidence of retinopathy was described in any of 
these patients13.  
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Niemeyer and Marquardt assumed retrograde trans-synaptic degeneration as a possible 
explanation of the ERG abnormalities, causing damage to the inner nuclear layer in the central 
retina and subsequent reduction of the cone ERG11. Other authors considered this assumption 
viable to explain the abnormal ERGs findings3,9.  
Given that our two patients had a normal retinal appearance in the setting of significant 
abnormalities in the ERG, we believe that it is possible that the retinal degeneration/dysfunction 
in Wolfram syndrome parallels the neurodegenerative process that underlies the disease. 
Although prior studies did not correlate age with onset of abnormal ERG findings, patients were 
examined late in their second decade or in their third decade of life, and both of our patients were 
in the 3rd decade of life, so the abnormal ERGs may be a relatively late ophthalmic manifestation 
of Wolfram syndrome and can only be demonstrated as retinal neurons die with advancing 
disease.  We found a normal ERG in a 9 year-old boy that we have examined at our Center. Of 
note, however, that Mayer et al3 presented  the case of a 3.5 year-old boy diagnosed with 
diabetes 6 months earlier, with optic atrophy, normal fundus, and abnormal ERG, which led the 
authors to conclude, perhaps incorrectly, that the nature of the optic atrophy was retinal.   
We would also like to posit that this retinal degeneration might be the result of 
mitochondrial dysfunction. Functional abnormalities in inner retinal activities examined with 
multifocal ERG and pattern ERG were previously described in patients with Leber's Hereditary 
Optic Neuropathy14. In another study, Miyata et al. described 8 patients with Autosomal 
Dominant Optic Atrophy caused by OPA1 mutations. They found that ERG light-adapted 
negative response and oscillatory potentials amplitudes were significantly reduced in the patient 
group15. Although most of these indicators describe ganglion cell function, others are only 
partially influenced by that. In particular, the reduction in oscillatory potential amplitudes 
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reflects alterations in inner plexiform layer feedback, suggesting that amacrine cells functioning 
could be primary or secondary related to mitochondrial dysfunction. It was also observed that 
oscillatory potential value decrease progressively with age15. Outer retinal abnormalities are also 
associated with mitochondrial diseases. Among these abnormalities, pigmentary retinopathy is 
the most frequent and has been associated with mtDNA mutations16,17. In 2010 Gronlund et al. 
studied 59 patients with a variety of mitochondrial diseases and found that 81% of cases had 
ophthalmologic abnormalities18. Overall, 28% of patients had abnormal retinal pigmentation. Of 
patients in  whom ERG was performed, 37% showed retinal dystrophy with abnormalities in 
both a- and b-waves under dark- and light-adapted conditions18.  These observations were also 
made in a previous paper by Zhu et al., that found pigmentary retinopathy and optic atrophy to 
be the most common ophthalmological manifestations in patients with confirmed mutations in 
well-defined primary mitochondrial diseases19.  
It has been recently suggested that the mechanism leading to optic nerve atrophy in WS is 
similar to that in mitochondrial-associated optic neuropathies such as Leber hereditary optic 
neuropathy (LHON)20. Although Wolframin is not a mitochondrial protein, being located in the 
endothelial reticulum (ER), one of its ascribed roles involves the strict ER–mitochondrial 
interaction in calcium exchanges. Hence Wolframin dysfunction could severely impact on 
calcium exchanges and mitochondrial oxidative phosphorylation leading to ER stress and 
apoptosis20. Because of the high reliance on mitochondrial-derived energy by neurons such as 
ganglion cells and photoreceptors, the correlation between mitochondrial disease and optic nerve 
atrophy can be explainable, and one can postulate a similar mechanism leading to photoreceptor 
dysfunction 21. Moreover, the heteroplasmy and the threshold effect that characterize 
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mitochondrial pathologies could explain why retinal dysfunction is only detected in a fraction of 
patients and with a delayed onset22. 
In this paper, we have provided additional support to the presence of retinal dysfunction 
as demonstrated by abnormal electroretinography in two patients with Wolfram syndrome and 
postulate that these are the result of photoreceptor degeneration possibly from abnormal 
mitochondrial function. ERGs should be obtained in patients with Wolfram syndrome and could 
be repeated to document progression of the disease or its response to emerging therapies.  
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Table 1. Literature about ERG abnormalities findings in patients with Wolfram Syndrome 
Reference Patient 
 Age and Sex Macula ERG Characteristics 
Gunn et al.9 1976 17 F Normal Dark-adapted elevated threshold and diminished amplitude 
Light-adapted normal response 
Dark- and light-adapted diminished oscillatory potential 
Abnormal dark adaptation 
 17 F Normal Dark-adapted elevated threshold and diminished amplitude 
Light-adapted elevated threshold and diminished amplitude 
Dark- and light-adapted diminished oscillatory potential 
Abnormal dark adaptation 
 17 M Normal Light-adapted elevated threshold and diminished amplitude 
Niemeyer at al.11 1977 19 F Normal Dark- and light-adapted very slightly reduced amplitudes  
No significant change in latency or implicit time 
Dark- and light-adapted diminished oscillatory potential 
Dark- and light-adapted elevated threshold at dark adaptation 
 16 M  
Normal 
Dark- and light-adapted very slightly reduced amplitudes  
No significant change in latency or implicit time 
Dark- and light-adapted diminished oscillatory potential 
Dark- and light-adapted elevated threshold at dark adaptation 
Barrett et al.12 1997 Not known 
(3 patients) 
Normal Dark- and light-adapted reduction in amplitude of response 
without significant change in latency 
Our study 22 F Normal Dark- and light-adapted reduction in amplitude of response 
 26 M Normal Dark- and light-adapted reduction in amplitude of response 
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Caption 
Figure 1. Combined images of Case 1. Right eye (A-B) and left eye (C-D) fundus photographs 
and fundus autofluorescence of a 22 years old woman show mild disc pallor in both eyes, 
but normal fundus appearance. 
Figure 2. Full-field ERGs for Case I and Case II. Nomenclature follows the terminology 
proposed by latest ISCEV update on full-field electroretinography23. Dark-adapted -24 
ERG (DA -24), Dark-adapted 0 ERG (DA 0), Light-adapted 0 ERG (LA 0) and Light-
adapted 30 Hz Flicker (LA 30 Hz) Recorded Using DTL Electrodes in a Control Case, in 
Case 1 (S1) and in Case 2 (S2). Low luminance stimulus evoked a response with reduced 
amplitude in b-wave in both patients under dark-adapted conditions (top row). In response 
to a high luminance stimulus (row 2), the a-wave amplitude was also reduced. Under 
light-adapted conditions that isolate cone responses, ERG amplitudes were reduced for 
both single flash and flicker stimuli (Rows 3, 4). 
Figure 3. Right and left (A-B) eye fundus photographs of a 26 years old man show marked disc 
pallor, without fundus abnormalities 
